Research & Bioregulators
Specialised compounds, Khavinson bioregulators and cardiovascular research peptides. 25 profiles, 4 sourceable from N1 Aminos.
ARA-290
ARA290 · Cibinetide
ARA-290 is a next-generation repair peptide that fixes damaged nerves and calms down overactive inflammation, without the side effects of older anti-inflammatory drugs. It’s engineered from erythropoietin (the hormone that makes red blood cells), but scientists removed the blood-building part and kept only the healing and protective powers—making it unique among peptides.
- Route
- Subcutaneous
- Dose
- 4 mg – 8 mg
- Cycle
- 4–8 weeks
Pinealon
Pinealon is a triamino-acid peptide complex (Glu-Asp-Gly) that restores pineal gland function to reestablish youthful circadian rhythms, melatonin production, and neuroprotection against age-related cognitive decline and neurodegeneration. Working at the epigenetic level, it regulates gene expression in brain cells to support cellular metabolism, antioxidant defense, and neuronal plasticity—the foundation of memory, learning, and resilience to stress and aging.
- Route
- Subcutaneous
- Dose
- 200 mcg – 500 mcg
- Cycle
- 8–12 weeks
SS-31
SS-31 is a mitochondria-targeted tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that selectively penetrates mitochondrial membranes to bind cardiolipin, stabilizing cristae architecture, optimizing electron transport chain efficiency, and preventing reactive oxygen species (ROS) leakage at the source—delivering 20-40% ATP production increases while reducing oxidative damage across aging tissues. Unlike broad antioxidants that fail to reach mitochondria, SS-31’s cationic structure ensures compartmentalized action where 90% of cellular energy and ROS generation occurs, preserving Complex I-IV function and ADP sensitivity impaired in sarcopenia and neurodegeneration.
- Route
- Subcutaneous
- Dose
- 5 mg – 10 mg
- Cycle
- 8–12 weeks
TB-500 (Thymosin Beta-4)
Thymosin Beta-4
TB-500, the synthetic 43-amino-acid version of Thymosin Beta-4, accelerates tissue repair by upregulating actin polymerization, promoting cell migration, angiogenesis, and anti-inflammatory cytokine profiles—achieving 61% wound re-epithelialization by day 7 versus saline controls while preventing scar formation through collagen organization. It sequesters actin monomers to facilitate cytoskeletal remodeling essential for endothelial cell movement, fibroblast proliferation, and myocyte regeneration across skin, muscle, tendon, ligament, heart, and cornea.
- Route
- Subcutaneous
- Dose
- 500 mcg – 1 mg
- Cycle
- 8–12 weeks
Vesilute
Vesilut · Glu-Asp
Research Goal: Evaluating the restoration of bladder wall muscle tone and epithelial tissue regeneration via peptide bioregulators.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days; typically repeated every 3–6 months
Bronchogen
AEDL · Ala-Glu-Asp-Leu peptide
Bronchogen is a specialized lung-healing peptide that repairs damaged respiratory tissue and turns down inflammation deep in your airways. If you’ve ever struggled with chronic coughing, shortness of breath, or that feeling of heaviness in your chest from ongoing inflammation, Bronchogen targets the root cause at the cellular level.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days; often repeated every 4–6 months
Cardiogen
AEDR · Ala-Glu-Asp-Arg peptide
Cardiogen is a heart-repair peptide that reverses the scarring and muscle weakness that make your heart fail or struggle after a heart attack. Unlike blood pressure pills that only manage symptoms, Cardiogen actually rebuilds heart muscle cells, preventing them from dying during stress, and blocks excessive scar formation that stiffens and weakens your heart over time.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days
Chonluten
Chonluten is a lung and respiratory peptide that awakens your lungs’ natural self-repair system and calms the chronic inflammation that keeps you wheezing and short of breath. If you’ve dealt with asthma, COPD, chronic bronchitis, or lingering damage from infection, Chonluten works at the genetic level to activate the genes responsible for rebuilding lung tissue.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days
PNC-27
PNC-27 is a groundbreaking anti-cancer peptide that selectively kills cancer cells by binding to HDM-2 protein on cancer cell membranes, then forming transmembrane pores that trigger immediate necrotic cell death through osmotic lysis—without requiring p53 tumor suppressor genes, allowing it to work against p53-null cancers resistant to conventional therapy. Laboratory studies show nearly 100% cancer cell elimination in leukemia and breast cancer lines while leaving normal cells completely unharmed due to HDM-2 expression exclusively on cancer cell membranes.
- Route
- Subcutaneous
- Dose
- 100 mcg – 500 mcg
- Cycle
- 8–12 weeks
Vesugen
Vesugen KED · KED tripeptide
Vesugen is a vascular-targeting peptide that penetrates endothelial cell membranes to activate Ki-67 and SIRT1 genes, upregulating longevity pathways and vascular regeneration signals while promoting collagen and elastin synthesis within blood vessel walls—achieving 53-61% improvements in vascular endothelial function and reversing age-related vascular stiffness through epigenetic gene expression modulation.
- Route
- Subcutaneous
- Dose
- 500 mcg – 2 mg
- Cycle
- 8–12 weeks
B7-33
B7-33 peptide · RXFP1 agonist B7-33
B7-33 is a heart-healing peptide that stops the scarring process in your heart, lungs, kidneys, and liver—organs that can be permanently damaged by chronic disease or injury. Fibrosis, the medical term for organ scarring, is like your body’s attempt at repair that goes wrong, creating stiff scar tissue instead of healthy tissue.
- Route
- Subcutaneous
- Dose
- 150 mcg – 500 mcg
- Cycle
- 4–8 weeks for acute fibrosis studies
Cartalax
AED · Ala-Glu-Asp
Cartalax is a joint-rescue peptide formulated to rebuild cartilage, reduce joint inflammation, and restore the mobility you lose with age or arthritis. Made from a simple three-amino-acid sequence, it’s deceptively powerful—it activates genes responsible for producing collagen, the structural protein that gives cartilage its cushioning strength and flexibility.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days
CJC-1295 (no DAC), Hexarelin
no DAC · CJC-1295 (No DAC)
CJC-1295 (No DAC) combined with Hexarelin creates a high-potency growth hormone stack that delivers powerful muscle growth, fat loss, and recovery benefits through synergistic hormone pulses. CJC-1295 without DAC acts like a natural signal from your brain to release growth hormone in short, strong bursts that mimic your body’s youthful sleep-time surges.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 4–6 weeks (shorter cycles prevent receptor desensitization)
Cortagen
Cortagen is a brain-protecting peptide derived from cortex proteins that repairs neural damage, boosts learning, and shields your nervous system from stress or aging decline. It works by upregulating neurotrophic factors like BDNF (brain-derived neurotrophic factor), which grow and protect neurons while enhancing synaptic plasticity—the brain’s ability to form new connections for memory and skills.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 4 weeks
Hexarelin
Research Goal: Analyzing peak GH pulse amplitude and the protective effects of Hexarelin on cardiac myocytes via CD36 receptors.
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 4 weeks on, followed by a 4-week washout to maintain pituitary sensitivity
Livagen
Livagen is an immune-rejuvenating peptide related to Epitalon that awakens dormant genes in your immune cells and restores youthful immune function by literally repackaging DNA in lymphocytes from tightly sealed (aged) to accessible (youthful). It induces chromatin decondensation—unpacking DNA—which reactivates silenced genes related to protein production and immune cell activity that naturally shut down with aging.
- Route
- Subcutaneous
- Dose
- 500 mcg – 2 mg
- Cycle
- 8–12 weeks
Mod GRF, Hexarelin
Mod GRF/Hexarelin represents peak GH secretagogue potency, combining sustained GHRH agonism with Hexarelin’s extreme receptor affinity for explosive, sustained GH elevation supporting maximal hypertrophy and strength. The blend produces among the highest recorded GH peaks, with neuroprotective and cardiovascular benefits from Hexarelin’s unique profile.
- Route
- Subcutaneous
- Dose
- 100 mcg – 150 mcg
- Cycle
- 4 weeks on, followed by a 4-week washout period
Ovagen
Ovagen is a Khavinson tripeptide bioregulator (Glu-Asp-Leu) primarily targeting liver and gastrointestinal tract function by directly modulating gene transcription patterns, resetting aged DNA to more youthful expression profiles that restore cellular resilience and repair capacity. Unlike pharmaceutical drugs that block or activate single targets, Ovagen penetrates cell and nuclear membranes to systematically reprogram gene expression, promoting hepatic cell proliferation while preventing cirrhotic scarring, and supporting mucosal barrier protection in the GI tract against antibiotics, chemotherapy, environmental toxins, and malnutrition.
- Route
- Subcutaneous
- Dose
- 10 mcg – 50 mcg
- Cycle
- 1–2 weeks (Note: Preclinical research often utilizes shorter cycles or maintenance phases)
Pancragen
Pancragen is a tetrapeptide bioregulator (Lys-Glu-Asp-Trp) that restores pancreatic cell function by penetrating cell membranes to reprogram DNA transcription patterns, specifically upregulating genes critical for pancreatic maturation (Ptf1a, Pdx1, Pax6) while suppressing apoptotic signals that destroy pancreatic cells. Research shows it reduces fasting glucose by up to 40%, normalizes insulin secretion dynamics, and improves glucose utilization efficiency—effects that persist weeks after treatment concludes, suggesting genuine gene expression resets rather than temporary suppression.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days; typically repeated every 4–6 months
Prostamax
Prostamax is a tetrapeptide bioregulator (derived from prostate tissue) that reduces chronic prostate inflammation by suppressing immune cell infiltration and vascular congestion while simultaneously promoting prostate cell repair through epigenetic gene regulation. Research in animal models shows 15-day treatment reduces swelling, lymphocyte infiltration, and scarring in chronic prostatitis, restoring normal urinary flow and function without blocking hormones like 5-alpha reductase inhibitors.
- Route
- Subcutaneous
- Dose
- 500 mcg – 1 mg
- Cycle
- 8–12 weeks
Testagen
KEDG · Anterior Pituitary Peptide (APP)
Testagen is a peptide bioregulator that restores youthful testosterone production by directly modulating pituitary gene expression to increase luteinizing hormone (LH) and thyroid-stimulating hormone (TSH) release, triggering downstream testosterone and thyroid hormone synthesis—addressing the root endocrine dysregulation underlying age-related hormone decline rather than supplying testosterone externally.
- Route
- Subcutaneous
- Dose
- 100 mcg – 300 mcg
- Cycle
- 8–12 weeks
Thymagen (Thymogen)
Thymogen
Research Goal: Investigating the restoration of immune homeostasis and the stimulation of T-cell maturation in models of immunodeficiency.
- Route
- Subcutaneous
- Dose
- 100 mcg – 500 mcg
- Cycle
- 10 days; often repeated every 3–6 months
Thymalin
Thymulin · Nonathymulin
Research Goal: Assessing the geroprotective (anti-aging) and immunomodulatory effects of the full thymic extract complex on longevity and organ function.
- Route
- Subcutaneous
- Dose
- 10 mg – 20 mg
- Cycle
- 10 days per cycle, repeated 1–2 times per year
Vilon
Vilon is the shortest bioactive peptide (Lys-Glu, just 2 amino acids) that acts as a potent chromatin regulator, inducing heterochromatin unrolling and activating previously silenced genes related to immune function, cardiovascular health, gastrointestinal integrity, and tumor suppression—effectively “turning on” genes that aging has silenced without activating abnormal genetic programs. Research demonstrates that Vilon induces chromatin deheterochromatinization with simultaneous activation of synthetic processes through ribosomal gene reactivation.
- Route
- Subcutaneous
- Dose
- 67 mcg – 667 mcg
- Cycle
- Short 5-day pulses, often repeated every 3–6 months
VIP
Research Goal: Analyzing the regulation of cytokine secretion and improvement of blood flow in pulmonary or cerebral research.
- Route
- Subcutaneous
- Dose
- 50 mcg – 200 mcg
- Cycle
- 30 days
Research compounds with a paper trail.
N1 Aminos tests every batch at an independent lab, ships tracked in 3–5 days, and publishes certificates of analysis on request.
Shop N1 Aminos →Code DOSING15 · 15% off first order
Where to trackNever miss a dose or a cycle end.
StackTracker turns any protocol on this site into a daily brief with one-tap logging, half-life graphs and lab-result tracking.
Start a free trial →